KROEMER Heyo | Dr. Margarete Fischer-Bosch-Institut fur Klinische Pharmakologie
スポンサーリンク
概要
関連著者
-
KROEMER Heyo
Dr. Margarete Fischer-Bosch-Institut fur Klinische Pharmakologie
-
Kroemer Heyo
Dr. Margarete Fischer-bosch Institute Of Clinical Pharmacology
-
Hofmann Ute
Dr. Margarete Fischer-bosch-institut Fur Klinische Pharmakologie
-
EICHELBAUM Michel
Dr. Margarete Fischer-Bosch-Institut fur Klinische Pharmakologie
-
Kroemer Heyo
Institut Fur Pharmakologie Ernst-moritz-arndt-universitat
-
Eichelbaum Michel
Dr. Margarete Fischer-bosch Institute Of Clinical Pharmacology
-
Hofmann Ute
Dr. Margarete Fischer-bosch Institute Of Clinical Pharmacology
-
Hofmann U
Dr. Margarete Fischer-bosch-institut Fur Klinische Pharmakologie
-
EICHELBAUM Michel
Margarete Fischer-Bosch Institut of Clinical Pharmacology
-
BOHNENSTENGEL Frank
Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology
-
Kroemer H
Dr. Margarete Fischer-bosch-institut Fur Klinische Pharmakologie
-
PECIA Monika
Dr. Margarete Fischer-Bosch-Institut fur Klinische Pharmakologie
-
HEINKELE Georg
Dr. Margarete Fischer-Bosch-Institut fur Klinische Pharmakologie
-
DILGER Karin
Dr. Margarete Fischer-Bosch-Institut fur Klinische Pharmakologie
-
GOLBS Ellen
Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology
-
JOHNSON Susanne
Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology
-
ENGEL Georg
Dr. Margarete Fischer-Bosch-Institut fur Klinische Pharmakologie
著作論文
- Determination of propafenone and its phase I and phase II metabolites in plasma and urine by high-performance liquid chromatography-electrospray ionization mass spectrometry
- High-performance liquid chromatographic determination of acrolein as a marker for cyclophosphamide bioactivation in human liver microsomes
- Direct gas chromatographic determination of dechloroethylcyclophosphamide following microsomal incubation of cyclophosphamide
- Prediction of CYP2D6-mediated polymorphic drug metabolism (sparteine type) based on in vitro investigations